These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8876929)

  • 1. Absorption of the anxiolytic pazinaclone in animals as a criterion for species selection for toxicity studies.
    Kondo T; Yoshida K; Tanayama S
    Arzneimittelforschung; 1996 Sep; 46(9):839-43. PubMed ID: 8876929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantiomeric toxicokinetics of the new isoindoline anxiolytic pazinaclone in rats and dogs.
    Kondo T; Yoshida K; Yamamoto M; Tanayama S
    Arzneimittelforschung; 1996 Jan; 46(1):11-14. PubMed ID: 8821511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioselective pharmacokinetics in animals of pazinaclone, a new isoindoline anxiolytic, and its active metabolite.
    Kondo T; Yoshida K; Yoshimura Y; Tanayama S
    Biopharm Drug Dispos; 1995 Dec; 16(9):755-73. PubMed ID: 8580400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the stereoselective pharmacokinetics of pazinaclone (DN-2327), a new anxiolytic, and its active metabolite after intravenous and oral single doses to dogs.
    Hussein Z; Mulford DJ; Bopp BA; Granneman GR
    Drug Metab Dispos; 1993; 21(5):805-10. PubMed ID: 7902240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective pharmacokinetics of pazinaclone, a new non-benzodiazepine anxiolytic, and its active metabolite in healthy subjects.
    Hussein Z; Mulford DJ; Bopp BA; Granneman GR
    Br J Clin Pharmacol; 1993 Oct; 36(4):357-61. PubMed ID: 12959315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of DN-2327, a new anxiolytic, in rats, dogs, and monkeys.
    Kondo T; Kurata Y; Yoshida K; Yoshimura Y
    Biol Pharm Bull; 1995 Feb; 18(2):330-6. PubMed ID: 7742808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantioselective determination of pazinaclone, a new isoindoline anxiolytic, and its active metabolite in rat plasma by high-performance liquid chromatography.
    Kondo T; Hamasaki K; Yamaguchi M; Aoki I; Yoshida K; Yoshimura Y; Tanayama S
    J Chromatogr B Biomed Appl; 1995 Apr; 666(2):291-7. PubMed ID: 7633605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption of the new anxiolytic compound deramciclane in rats, dogs and rabbits.
    Lengyel J; Bolehovszky A; Klebovich I; Aberman M; Magyar K
    Arzneimittelforschung; 1998 May; 48(5):455-60. PubMed ID: 9638311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of the histamine H1-receptor antagonist ebastine and its active metabolite carebastine in rats, guinea pigs, dogs and monkeys.
    Matsuda M; Sakashita M; Mizuki Y; Yamaguchi T; Fujii T; Sekine Y
    Arzneimittelforschung; 1994 Jan; 44(1):55-9. PubMed ID: 7907872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of dog and rat plasma for metabolites of a new isoindoline anxiolytic, DN-2327, by liquid chromatography/thermospray mass spectrometry and tandem mass spectrometry.
    Kondo T; Yoshida K; Tanayama S
    Biol Mass Spectrom; 1994 Jun; 23(6):323-9. PubMed ID: 7913625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic disposition of 6-ethyl-3-(1H-tetrazol-5-yl)-chromone, a new antiallergic agent, in the rat, guinea-pig, rabbit, dog and monkey.
    Kanai Y; Nakai Y; Nakajima N; Tanayama S
    Xenobiotica; 1979 Jan; 9(1):33-50. PubMed ID: 104449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption of the beta-adrenergic-blocking agent, nadolol, by mice, rats, hamsters, rabbits, dogs, monkeys, and man: an unusual species difference.
    Dreyfuss J; Shaw JM; Ross JJ
    Xenobiotica; 1978 Aug; 8(8):503-8. PubMed ID: 29379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of the anxiolytic beta-carboline derivative abecarnil in the mouse, rat, rabbit, dog, cynomolgus monkey and baboon. Studies on species differences.
    Krause W; Mengel H
    Arzneimittelforschung; 1990 May; 40(5):522-9. PubMed ID: 1974427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 2nd communication: Absorption and excretion in rabbits, dogs and monkeys after a single administration of 14C-NS-49.
    Mukai H; Watanabe S; Morino A
    Arzneimittelforschung; 1999 Jun; 49(6):527-32. PubMed ID: 10417870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute inhalation toxicity studies in several animal species of an ethylene oxide/propylene oxide copolymer (UCON 50-HB-5100).
    Hoffman GM; Newton PE; Thomas WC; Birnbaum HA; Kennedy GL
    Drug Chem Toxicol; 1991; 14(3):243-56. PubMed ID: 1935705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of remoxipride in different species. Species differences in metabolism.
    Widman M; Nilsson LB; Bryske B; Lundström J
    Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pazinaclone. A 77000, DN 2327.
    Drugs R D; 1999 Jul; 2(1):57-9. PubMed ID: 10610295
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental studies on absorption, distribution and excretion of fosfomycin. I. Absorption distribution and excretion of fosfomycin calcium salt (author's transl)].
    Fujita M; Tomono N; Abe M; Hosoi K; Sato T
    Jpn J Antibiot; 1975 Jun; 28(3):309-13. PubMed ID: 1152284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.